Search Results for 'Urol Oncol'

William J.

• tawny-fly
• 6 Slides

Gradishar. . MD, FACP. Betsy . Bramsen. Profess...

Testicular and

• pamella-moone
• 55 Slides

E. xtragonadal. Germ . C. ell . T. umors: Focus ...

Thomas E. Keane

• danika-pritchard
• 35 Slides

Medical University of South Carolina . Charleston...

T o Starve Cancer to Death!

• tatiana-dople
• 10 Slides

——. The Anti-angiogenesis . E. ffects in the ...

Jon Trent, MD, PhD Professor of Medicine

• jane-oiler
• 0 Slides

Sarcoma . Medical Oncology. The University of . M...

Where we are with targeted

• stefany-barnette
• 32 Slides

therapies . for . cholangiocarcinoma. Professor J...

Antiangiogenic Agents in Advanced NSCLC

• ellena-manuel
• 0 Slides

Jared Weiss, MD . Assistant . Professor of Medici...

Supplemental Figure 1. Mutation frequencies in adenocarcinoma of the lung

• giovanna-bartolotta
• 0 Slides

Data source: . Wang R, Pan Y, Li C, et al. Analys...

James L. Gulley M.D. , Ph.D.,

• tatyana-admore
• 0 Slides

F.A.C.P. .. Head, Immunotherapy Section. Chief, G...

Fellows Lecture CRC & Anal Cancer

• liane-varnes
• 0 Slides

Treatment of CRC by Stage. Colon cancer. Stage I:...

Andrew H. Ko, MD University of California San Francisco

• test
• 0 Slides

Gastrointestinal Oncology Program. Treatment of m...

EGFR-Mutated Advanced NSCLC

• sherrill-nordquist
• 0 Slides

The Coming Paradigm Shift. Faculty. Suresh S. Ram...

Alexander Olinger , PharmD

• mitsue-stanley
• 0 Slides

PGY-2 Oncology Pharmacy Resident. Pharmacy Grand...

Sipuleucel -T Survival Benefit

• calandra-battersby
• 0 Slides

Sipuleucel. -T was approved based on HR of 0.775 ...

Cancer Unknown Primary Sarah W. Gordon, DO

• olivia-moreira
• 0 Slides

Assistant Professor. Virginia Commonwealth Univer...

19 th Annual NOCR Meeting

• cheryl-pisano
• 0 Slides

Session I: Breast Cancer. Bone Directed Therapy ...

IMMUNOTHERAPY Group 6 Melinda Bachini, Thelma Brown, Jean Di Carlo-Wagner, Bob Riter, Chris Kinsing

• conchita-marotz
• 0 Slides

IMMUNOTHERAPY. Preventative. Vaccines. HPV. Hepa...

ADVANCES IN THERAPY FOR SARCOMA AND GIST

• ellena-manuel
• 0 Slides

Angela . Cioffi. , MD. Sarcoma Research Program c...

Managing Advanced Renal Cell

• debby-jeon
• 0 Slides

Carcinoma: Balancing . Efficacy with Quality of L...

It takes more than milk to improve bone health!!

• aaron
• 0 Slides

Lawrence Drudge-Coates. Urological Oncology Clini...

CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data

• min-jolicoeur
• 22 Slides

CDK 4/6 Inhibitors in Breast Cance...

Ezra W Cohen University of California, San Diego

• natalia-silvester
• 76 Slides

Ezra W Cohen University of California, San Diego...

Michael A. Postow, MD

• kittie-lecroy
• 37 Slides

Michael A. Postow, MD Assistant Attending Physici...

The Role of Antiangiogenic Agents

• luanne-stotts
• 25 Slides

The Role of Antiangiogenic Agents in the Changin...

Patient Selection for PARP

• sherrill-nordquist
• 28 Slides

Inhibitors:. Purpose and Practicalities . Present...

SPN and Lung Cancer Adam J. Hayek, DO

• sequest
• 68 Slides

PGY-6. Pulmonary and Critical Care Fellow . GOALS....

DRA. CRUZ MORALES GEORGINA R1GO

• bubbleba
• 86 Slides

TUMORES DEL ESTROMA GONADAL. Temario. Introducció...

The Nurse View: Practice

• conterc
• 28 Slides

Pearls in . the Use . of . Immune . Checkpoint Inh...

Didier Coquoz Chemotherapy-2015

• rayfantasy
• 19 Slides

Valencia. , Spain. August 04- 06, 2015. Evolution...

• warlikebikers
• 56 Slides

cancer. , right vs . left. : . how. to take . it....

Anticoagulant Options for the Management of Acute Cancer-Associated Thrombosis

• collectmcdonalds
• 103 Slides

Presented by. Faculty/Presenter Disclosure. Facult...

ContentslistsavailableatEuropeanJournalofOncologyNursingjournalhomepag

• eleanor
• 7 Slides

ExerciseApositivefeatureonfunctioningindailylifedu...

ContentslistsavailableatSeminarsinCancerBiologyjournalhomepagewwwelsev

• audrey
• 15 Slides

DecodingandtargetingthemolecularbasisofMACC1-drive...

Immuno-Oncology Adverse Event Management

• everly
• 25 Slides

Why is it different? . Why is it important?. Dr Av...

Screening, Geriatric Assessment and Interventions

• layla
• 69 Slides

Pierre . Soubeyran. and Siri Rostoft. Disclosure....

Understanding Risk Factors of Cardiovascular Disease and Management Guidance for Men on Androgen De

• jacey
• 26 Slides

Prostate Cancer . US Medical Affairs, Research . a...

Thomas E. Keane Medical University of South Carolina

• valerie
• 35 Slides

Charleston, SC. Bones, Hot Flashes, and ADT Use Wi...

Mechanisms of ALK Resistance & Implications for Treatment

• evans
• 22 Slides

Robert C. Doebele, MD, PhD. Associate Professor, ....

Case Study: A P atient

• faith
• 44 Slides

with PV and . Debilitating . S. ymptoms on HU. Srd...

Fulvestrant 500 mg versus

• elena
• 30 Slides

anastrozole. as first-line treatment for advanced...